These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17824377)

  • 1. [Adverse effects and insufficient information in Fass].
    Ekholm ML
    Lakartidningen; 2007 Jul 25-Aug 7; 104(30-31):2179. PubMed ID: 17824377
    [No Abstract]   [Full Text] [Related]  

  • 2. [Unclear on dose adjustment in renal impairment].
    Asker-Hagelberg C; Rydberg D; Hentschke M; Holm L; Rosenborg S; Elinder CG
    Lakartidningen; 2013 May 22-28; 110(21):1030-2. PubMed ID: 23805768
    [No Abstract]   [Full Text] [Related]  

  • 3. [The enclosed notes with too much information].
    Weismann K; Larsen FG
    Ugeskr Laeger; 2001 Aug; 163(35):4762-4. PubMed ID: 11572057
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug information: how much is too much? Suggestions for improving the sources of drug information.
    Devetski RL
    Indiana Med; 1986 Apr; 79(4):368-9. PubMed ID: 3711651
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of medicines information for patient safety.
    Pappa D; Telonis P; Stergioulas LK
    J Telemed Telecare; 2006; 12 Suppl 1():34-6. PubMed ID: 16884574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Scrutinizing information:"Negative publicity is the best sanction". The text of FASS (a drug index) is not an absolute norm].
    Finer D
    Lakartidningen; 1996 May; 93(21):2020-2, 2027-8. PubMed ID: 8649085
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fass has reached the limit of decency!].
    Andersson B
    Lakartidningen; 2005 May 16-22; 102(20):1564; author reply 1564. PubMed ID: 15973891
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monographs of the common catalog].
    Strøm I
    Tidsskr Nor Laegeforen; 1993 Jun; 113(16):2012-3. PubMed ID: 8322357
    [No Abstract]   [Full Text] [Related]  

  • 9. [Activities of a regional drug monitoring center. What to evaluate, how and for what purpose].
    Péré JC; Haramburu F; Bégaud B; Barat C; Laborde B; Albin H
    Therapie; 1987; 42(4):351-8. PubMed ID: 3686468
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electronic version of the Fass is also considered to be reliable].
    Hedstrand AG; Iwarson S
    Lakartidningen; 1999 Mar; 96(11):1348-9. PubMed ID: 10194920
    [No Abstract]   [Full Text] [Related]  

  • 11. [No information about interactions with nicotine in the Fass].
    Wikström G
    Lakartidningen; 2004 Apr; 101(17):1543. PubMed ID: 15150962
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hazardous drugs, high risk patients and high risk physicians].
    Karlmark B
    Lakartidningen; 1991 Nov; 88(48):4115. PubMed ID: 1956247
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pfizer's answer to Bengt Jarhult: joint challenge to develop methods for discovery of low-frequency adverse effects].
    Dahl E; Lindstrand G
    Lakartidningen; 2005 Feb 28-Mar 6; 102(9):665. PubMed ID: 15804040
    [No Abstract]   [Full Text] [Related]  

  • 14. [Information about adverse effects of drugs is not included in Fass (Swedish drug catalog)].
    Jacks B
    Lakartidningen; 1995 Oct; 92(41):3772. PubMed ID: 7564626
    [No Abstract]   [Full Text] [Related]  

  • 15. [A study at a health center. "Guide" in the Fass can result in overprescription of penicillin to children].
    Rockborn E
    Lakartidningen; 2001 May; 98(19):2334-5. PubMed ID: 11402988
    [No Abstract]   [Full Text] [Related]  

  • 16. [Disease manifestations in the otorhinolaryngologic region as the sequelae to side effects of drugs].
    Fleischer K
    HNO; 1983 Jul; 31(7):219-27. PubMed ID: 6885525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOSPITAL DRUG INFORMATION SERVICES.
    FERGUSON JA
    Can Hosp; 1965 Aug; 42():31-3. PubMed ID: 14341640
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adverse effects of drugs and computerized registries--a threat or a possibility?].
    Bergman U; Linnarsson R; Boethius G; Matell G; Keisu M; Peterson H; Kalles I; Wiholm BE; Krakau I; Westerholm B
    Lakartidningen; 1989 Apr; 86(16):1506-8. PubMed ID: 2725139
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmaca Fennica and the information about parallel pharmaceutical derivatives].
    Kettunen K
    Duodecim; 2003; 119(17):1686; author reply 1687. PubMed ID: 14587451
    [No Abstract]   [Full Text] [Related]  

  • 20. [Systematic follow up of inquiries about adverse drug reactions: a 9 month experience].
    Begaud B; Haramburu F; Père JC; Lorson B; Albin H; Dangoumau J
    Therapie; 1982; 37(4):433-5. PubMed ID: 7135326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.